China Isotope & Radiation Corp - ESG Rating & Company Profile powered by AI
This ESG rating covers seventeen United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Life below Water'. Alternative corporations in the scoring peer group for China Isotope & Radiation Corp are displayed. This page includes a Q&A section for China Isotope & Radiation Corp.
China Isotope & Radiation Corp in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 6.4, social score of 5.3 and governance score of 4.8.
5.5
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Calmark Sweden AB | 8.0 | High |
1 | CHC Healthcare Group | 8.0 | High |
82 | Rua Life Sciences PLC | 5.8 | High |
82 | Theraclion SA | 5.8 | High |
93 | China Isotope & Radiation Corp | 5.5 | High |
93 | Clearpoint Neuro Inc | 5.5 | High |
93 | PAVmed Inc | 5.5 | High |
... | ... | ... | |
260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
260 | Zynex Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does China Isotope & Radiation Corp have an accelerator or VC vehicle to help deliver innovation?
Does China Isotope & Radiation Corp disclose current and historical energy intensity?
Does China Isotope & Radiation Corp report the average age of the workforce?
Does China Isotope & Radiation Corp reference operational or capital allocation in relation to climate change?
Does China Isotope & Radiation Corp disclose its ethnicity pay gap?
Does China Isotope & Radiation Corp disclose cybersecurity risks?
Does China Isotope & Radiation Corp offer flexible work?
Does China Isotope & Radiation Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does China Isotope & Radiation Corp disclose the number of employees in R&D functions?
Does China Isotope & Radiation Corp conduct supply chain audits?
Does China Isotope & Radiation Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does China Isotope & Radiation Corp conduct 360 degree staff reviews?
Does China Isotope & Radiation Corp disclose the individual responsible for D&I?
Does China Isotope & Radiation Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does China Isotope & Radiation Corp disclose current and / or historical scope 2 emissions?
Does China Isotope & Radiation Corp disclose water use targets?
Does China Isotope & Radiation Corp have careers partnerships with academic institutions?
Did China Isotope & Radiation Corp have a product recall in the last two years?
Does China Isotope & Radiation Corp disclose incidents of discrimination?
Does China Isotope & Radiation Corp allow for Work Councils/Collective Agreements to be formed?
Has China Isotope & Radiation Corp issued a profit warning in the past 24 months?
Does China Isotope & Radiation Corp disclose parental leave metrics?
Does China Isotope & Radiation Corp disclose climate scenario or pathway analysis?
Does China Isotope & Radiation Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does China Isotope & Radiation Corp disclose the pay ratio of women to men?
Does China Isotope & Radiation Corp support suppliers with sustainability related research and development?
Does China Isotope & Radiation Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does China Isotope & Radiation Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is China Isotope & Radiation Corp involved in embryonic stem cell research?
Does China Isotope & Radiation Corp disclose GHG and Air Emissions intensity?
Does China Isotope & Radiation Corp disclose its waste policy?
Does China Isotope & Radiation Corp report according to TCFD requirements?
Does China Isotope & Radiation Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does China Isotope & Radiation Corp disclose energy use targets?
Does China Isotope & Radiation Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does China Isotope & Radiation Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for China Isotope & Radiation Corp
These potential risks are based on the size, segment and geographies of the company.
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services, and Other Business segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.